12. Details institutional-level impact of research defunding on academic medicine.
7. Nature. “U.S. Scientists Consider Fleeing Abroad Amid Massive Funding Cuts.” Nature News, April 2025.
14. Reports on the increasing migration of U.S. researchers to international posts.
8. Gallup, Inc. “Rising Drug Costs and Public Sentiment in the U.S.” Survey results, June 2025.
16. Tracks public concern over skyrocketing drug prices post-tariff.
9. Columbia University Medical Center. Interview with Dr. Paula Castaño. Conducted March 2025.
18. Offers firsthand account of how research trial cancellations impact patient care.
10. Johns Hopkins Bloomberg School of Public Health. Interview with Dr. Tom Inglesby. February 2025.
20. Critiques the dismantling of CDC infrastructure and pandemic preparedness.
11. Stanford Health Care. Interview with Dr. Thomas K. Lew. January 2025.
22. Recounts the ER treatment of an uninsured liver failure patient affected by coverage gaps.
12. Harvard Medical School. “SYNGAP1 Research and Terminated Grants: Faculty Impact Summary.” Internal memo, February 2025.
24. Confirms the termination of critical neuroscience research projects.
13. American Association for Cancer Research. 2025 Emergency Research Grants Announcement. April 2025.
26. Announces an unprecedented $15 million emergency fund to support defunded researchers.
14. Centers for Disease Control and Prevention. Epidemic Intelligence Service Layoff Report. April 2025.
28. Documents the layoff of all first-year public health outbreak responders.
15. British National Health Service. “Galleri Cancer Detection Pilot: Interim Results.” NHS Research Directorate, May 2025.
30. Reports outcomes from the UK’s national rollout of multi-cancer early detection tests.
16. PATH and WHO. RTS,S and R21 Malaria Vaccine Distribution Data. Updated June 2025.
32. Tracks successful implementation of malaria vaccines across Africa.
17. UNAIDS. Cabotegravir Rollout Impact Summary: Brazil and South Africa. Global HIV Prevention Report, 2025.
34. Documents early success of long-acting HIV prevention therapies.
18. Vertex Pharmaceuticals and CRISPR Therapeutics. Casgevy Therapy for Sickle Cell Disease: Patient Outcomes. Clinical Release, February 2025.
36. Announces CRISPR-based gene therapy results in patients with blood disorders.
19. World Health Organization. Global Polio Surveillance Update. Accessed July 2025.
38. Confirms the near-eradication of wild polio globally, including remaining case counts.
20. Gavi, The Vaccine Alliance. “Zika and mRNA Vaccine Trials: Global Pipeline Review.” Technical Brief, April 2025.
40. Describes global expansion of mRNA vaccine technology beyond COVID-19.
21. New Zealand Ministry of Health. Primary Mental Health Integration Strategy: Annual Report 2025.
42. Summarizes how mental health has been embedded into national healthcare delivery.
22. Canadian Institute for Health Information. Mental Health Access and Digital Therapy Expansion. June 2025.
44. Analyzes the growth of teletherapy and destigmatized care across Canada.
23. American Hospital Association. Impact of Drug Tariffs on Hospital Formularies. Policy Brief, July 2025.
46. Assesses how rising drug import costs are affecting U.S. hospitals and patient care.
24. Congressional Research Service. The U.S. Pharmaceutical Supply Chain: Dependence and Disruption. Updated January 2025.
48. Evaluates vulnerabilities in the U.S. drug supply chain and reliance on foreign manufacturing.
25. UMass Chan Medical School. Interview with Dr. Rachael Sirianni. February 2025.
50. Captures the emotional and professional toll of defunded medical researchers.
26. University of Mississippi. Interview with Dr. Eden Tanner. March 2025.
52. Reveals the human frustration behind truncated cancer research projects.